Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene represents a pseudogene with sequence similarity to part of general transcription factor II, I (GTF2I). Pseudogenes typically do not encode functional proteins and are considered noncoding elements of the genome. However, some pseudogenes can exert regulatory effects on their protein-coding counterparts, often through RNA-based mechanisms such as competing endogenous RNA or microRNA decoy activity, though no evidence exists for such a function in this particular pseudogene. ENSG00000232546 is not considered a therapeutic target and is not associated with any disease pathology or drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of general transcription factor II, I.